End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1738 SEK | -2.91% | +5.59% | -22.76% |
May. 14 | Cell Impact AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Cell Impact AB Signs Main Agreement with F.C.C | CI |
Business Summary
Number of employees: 80
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Advanced Flow Plates
98.5
%
| 77 | 99.9 % | 47 | 98.5 % | -39.30% |
Services
1.5
%
| 0 | 0.1 % | 1 | 1.5 % | +569.52% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
95.2
%
| 73 | 95.2 % | 45 | 95.2 % | -38.42% |
Sweden
2.1
%
| 1 | 1.8 % | 1 | 2.1 % | -26.46% |
Asia
1.9
%
| 2 | 2.5 % | 1 | 1.9 % | -51.83% |
Other Europe
0.7
%
| 0 | 0.6 % | 0 | 0.7 % | -26.39% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vallin
CEO | Chief Executive Officer | 47 | 20-12-31 |
Human Resources Officer | 52 | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 21-12-31 | |
Mats Franzén
CHM | Chairman | 55 | 22-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 217,800 | 0 | 0 | 74.60 % |
Stock B | 1 | 591,450,032 | 441,406,921 ( 74.63 %) | 0 |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-22.76% | 9.61M | |
+64.60% | 4.1B | |
+1.12% | 2.05B | |
+1.73% | 2.01B | |
+3.25% | 1.95B | |
+4.27% | 1.52B | |
-6.45% | 1.54B | |
+16.61% | 1.38B | |
-31.92% | 1.24B | |
-20.56% | 1.19B |
- Stock Market
- Equities
- CI Stock
- Company Cell Impact AB